Attention Investors
Kindly note the Change in PAY IN for BSE A/C No. : 1201250000000691 (CDSL), if you have an NSDL A/C, kindly use INTER DEPOSITORY SLIP. For assistance, please call OR contact: Mr. Dadu, 98339 89807 / 022-6145 1000.    |   Exchanges / Depository: Prevent Unauthorized Transactions in your Trading / Demat account --> Update your Mobile Numbers / email IDs with your Stock Brokers / Depository Participant. Receive alerts on your Registered Mobile / email IDs for trading account transactions and all debit and other important transactions in your demat account directly from Exchange / Depository on the same day ......................Issued in the interest of Investors."     |    KYC : "KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."     |    ASBA-IPO : "No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
 ««+1  ««-1
 
 
Genpharmasec LtdIndustry : Trading
BSE Code:531592NSE Symbol: Not ListedP/E(TTM):39.2
ISIN Demat:INE861N01036Div & Yield %:0EPS(TTM):0.05
Book Value(Rs):1.1960288Market Cap ( Cr.):108.53Face Value(Rs):1
    Change Company 
Date Headline
07-Apr-25 Genpharmasec Ltd - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
20-Mar-25 Genpharmasec to hold board meeting
19-Mar-25 Genpharmasec Ltd - Board Meeting Intimation for Separate Meeting Of Independent Directors Of The Company To Be Held On M..
12-Feb-25 Genpharmasec Ltd - Announcement under Regulation 30 (LODR)-Newspaper Publication
11-Feb-25 Genpharmasec consolidated net profit rises 1200.00% in the December 2024 quarter
04-Feb-25 Genpharmasec to declare Quarterly Results
14-Nov-24 Genpharmasec Ltd - Announcement under Regulation 30 (LODR)-Newspaper Publication
13-Nov-24 Genpharmasec consolidated net profit rises 6900.00% in the September 2024 quarter
13-Nov-24 Genpharmasec standalone net profit rises 9900.00% in the September 2024 quarter
07-Nov-24 Genpharmasec announces board meeting date
<< < 1 2 > >>